Product Program year 2021 Source: CMS Open Payments

Zephyr Pacemaker

Device Cardiac Rhythm Management

PDI 05414734501712

Open in the dashboard

General payments

$1,120

40 payments

Research payments

$0

0 payments

Through program year 2021, $1,120 in general payments and $0 in research payments were reported against Zephyr Pacemaker (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $1,120 40

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $1,120 40 payments
Top recipients General payments · program year 2021
  1. Nasser Lakkis Interventional Cardiology · Mobile, AL $123 11% · 3 payments
  2. Donald Foster Nurse Practitioner, Acute Care · Houston, TX $116 10% · 2 payments
  3. Donald Foster Pediatrics · Little Rock, AR $98 9% · 3 payments
  4. Jeffrey Berman Cardiovascular Disease · Trumbull, CT $74 7% · 2 payments
  5. John Suffredini Interventional Cardiology · Houston, TX $72 6% · 1 payment

The top 5 of 31 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $294 26% · 11 practitioners
  2. Interventional Cardiology Internal Medicine $282 25% · 6 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $184 16% · 6 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $141 13% · 2 practitioners
  5. Pediatrics $98 9% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $528 47% · 8 recipients
  2. Arkansas $136 12% · 3 recipients
  3. California $128 11% · 7 recipients
  4. North Carolina $115 10% · 4 recipients
  5. Michigan $106 9% · 5 recipients

The top 5 of 9 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

40 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record